IDEXX LABORATORIES INC /DE (IDXX) - Comprehensive Stock Analysis & Investment Research
Company Overview & Business Profile
IDEXX LABORATORIES INC /DE (Stock Symbol: IDXX) is a leading company in the Life Sciences sector , specifically operating within the In Vitro & In Vivo Diagnostic Substances industry. The organization employs approximately 9200 professionals worldwide . The company has established itself as a major market leader with significant institutional backing.
Financial Performance & Key Metrics Analysis
Annual Revenue: $4037 million generating a 22.0% net profit margin .
Market Capitalization: $52710 million - Classified as a large-cap stock with institutional-grade stability.
Return on Equity (ROE): 109.4% - Exceptional shareholder return efficiency, indicating strong management effectiveness.
Advanced AI Stock Prediction & Price Target Analysis
🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for IDEXX LABORATORIES INC /DE stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.
Market Position & Competitive Advantage Analysis
IDEXX LABORATORIES INC /DE strategically competes in the highly dynamic In Vitro & In Vivo Diagnostic Substances marketplace, positioning itself as a dominant large-cap market leader with significant competitive moats and institutional investor confidence . The company demonstrates robust operational efficiency through strong free cash flow generation of $605 million annually , complemented by impressive 41.1% year-over-year cash flow growth. The company maintains a healthy 60.4% gross margin, indicating strong pricing power and operational efficiency.